Neurocrine Biosciences (NBIX) Share-based Compensation Growth (5y) (2015 - 2026)
Neurocrine Biosciences (NBIX) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.70% |
| Dec 31, 2025 | 22.78% |
| Sep 30, 2025 | 15.00% |
| Jun 30, 2025 | 12.35% |
| Mar 31, 2025 | 18.29% |
| Dec 31, 2024 | 25.53% |
| Sep 30, 2024 | 15.37% |
| Jun 30, 2024 | 19.21% |
| Mar 31, 2024 | 23.01% |
| Dec 31, 2023 | 23.43% |
| Sep 30, 2023 | 29.61% |
| Jun 30, 2023 | 42.03% |
| Mar 31, 2023 | 14.95% |
| Dec 31, 2022 | 26.46% |
| Sep 30, 2022 | 33.40% |
| Jun 30, 2022 | 38.00% |
| Mar 31, 2022 | 32.75% |
| Dec 31, 2021 | 34.92% |
| Sep 30, 2021 | 42.56% |
| Jun 30, 2021 | 31.40% |